Total Holdings
31
As of Oct 4, 2026
Invesco Pharmaceuticals ETF
PJPNYSEARCAInvescoEquity
$124.46Today:- (-)1Y +33.02%
As of Oct 16, 2026 close
- Assets (AUM)
- $571.00M
- Expense ratio
- 0.58%
- Dividend yield
- 0.90%
- Holdings
- 31
- 52-week range
- $92.73$131.68
- Volume (live)
- -
- Avg. volume (3M)
- 36.34K
PJP ETF Holdings: Invesco Pharmaceuticals ETF
Every listed position with its portfolio weight, plus sector breakdown and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Top 10 Holdings
50.3%
Share of fund assets
Assets (AUM)
$571.00M
Total fund assets
Expense Ratio
0.58%
Annual management fee
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 28 of 31 PJP Holdings by Portfolio Weight
Holdings as of Oct 4, 2026. Ticker, name, asset type and portfolio weight for each position. Fund disclosures available to us list the largest 28 positions.
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | AbbVie Inc. | Stock | 5.67% |
| 2 |  | Gilead Sciences, Inc. | Stock | 5.58% |
| 3 |  | Pfizer Inc. | Stock | 5.58% |
| 4 |  | Johnson & Johnson | Stock | 5.42% |
| 5 |  | Eli Lilly and Company | Stock | 5.31% |
| 6 |  | Merck & Co., Inc. | Stock | 5.29% |
| 7 |  | Amgen Inc. | Stock | 5.22% |
| 8 |  | Abbott Laboratories | Stock | 4.95% |
| 9 |  | Amneal Pharmaceuticals, Inc. | Stock | 3.71% |
| 10 |  | Tarsus Pharmaceuticals Inc | Stock | 3.61% |
| 11 |  | Ligand Pharmaceuticals Incorporated | Stock | 3.52% |
| 12 |  | Viatris Inc. | Stock | 3.44% |
| 13 |  | United Therapeutics Corporation | Stock | 3.42% |
| 14 |  | Harmony Biosciences Holdings Inc | Stock | 3.35% |
| 15 |  | Biogen Inc. | Stock | 3.26% |
| 16 |  | Perrigo Company plc | Stock | 3.22% |
| 17 |  | Travere Therapeutics Inc | Stock | 3.20% |
| 18 |  | Innoviva, Inc. | Stock | 3.17% |
| 19 |  | ANI Pharmaceuticals, Inc. | Stock | 3.12% |
| 20 |  | Ocular Therapeutix Inc | Stock | 3.10% |
| 21 |  | Corcept Therapeutics Incorporated | Stock | 3.08% |
| 22 |  | Liquidia Corporation | Stock | 3.06% |
| 23 |  | Regeneron Pharmaceuticals, Inc | Stock | 3.03% |
| 24 |  | Bristol-Myers Squibb Company | Stock | 2.98% |
| 25 |  | Jazz Pharmaceuticals plc | Stock | 2.96% |
| 26 |  | Prestige Consumer Healthcare Inc | Stock | 2.92% |
| 27 |  | Collegium Pharmaceutical Inc | Stock | 2.65% |
| 28 | NMFQS:AGPXX | Short-Term Investment Trust - Invesco Government & Agency Portfolio | Cash | 0.04% |
Source: Fund holdings disclosures. Data as of Oct 4, 2026. Data sources and methodology
Frequently Asked Questions About Invesco Pharmaceuticals ETF Holdings
What are the top holdings in PJP?
As of Oct 4, 2026, Invesco Pharmaceuticals ETF (PJP) holds 31 securities. The largest are AbbVie Inc. (5.67%), Gilead Sciences, Inc. (5.58%), Pfizer Inc. (5.58%). The holdings table lists each position by portfolio weight with its ticker, name and asset type.
How concentrated is PJP's portfolio?
As of Oct 4, 2026, the 10 largest positions make up 50.3% of PJP's assets. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly.
What is PJP's sector allocation?
The Sector Allocation chart shows how PJP distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does PJP invest in?
PJP's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is PJP ETF?
PJP's diversification can be assessed by reviewing its 31 holdings (as of Oct 4, 2026), sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.